FDA clears Toshiba’s Aquilion RXL

FDA clears Toshiba’s Aquilion RXL

Toshiba America Medical Systems, Inc. has received FDA clearance for its Aquilion RXL Edition CT system, which reconstructs images faster that previous models and includes the latest dose reduction technologies.

The system features Toshiba’s Adaptive Iterative Dose Reduction 3D (AIDR 3D), an algorithm designed to work in both the raw data and image data spaces, reducing noise while attempting to maintain image quality. The system also features Toshiba’s NEMA XR 25 Dose Check Software, which alerts users to the radiation dose administered to patients.